Dr. Ghazala S. Hayat, MD

Dr. Hayat practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Hayat's NPI, 1710902515, was assigned on July 13, 2006. Dr. Hayat holds Missouri license R8F08.

Dr. Hayat's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Hayat's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. Dr. Hayat is also affiliated with SSM Health St. Mary's Hospital - St. Louis. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Hayat to 1 more hospital, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hayat practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hayat's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hayat is licensed in Missouri.

CMS data shows 457 Medicare services from Dr. Hayat across 12 procedure codes in 2024, for 220 Medicare patients. Medicare paid $28,945 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 220 Medicare patients who saw Dr. Hayat in 2024. The largest group is under 65, with 83 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hayat's median patient age at 65, with 53% women.

In 2024, Dr. Hayat wrote 1,296 Medicare Part D claims for 182 patients. 79% of them were for generic drugs. CMS names the drug for 1,078 of them, across 21 drugs with 11 or more claims each, at $3,598,567 in total drug cost. In 2023, CMS named 944 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Hayat for performance year 2024, reported as part of a group. Dr. Hayat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hayat as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 375 general payments to Dr. Hayat from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $123,022.